Cargando…
Chloroquine increases the anti-cancer activity of epirubicin in A549 lung cancer cells
The present study investigated whether the autophagy inhibitor chloroquine (CQ) can improve the sensitivity of the A549 lung cancer cell line to epirubicin (EPI). The Cell Counting Kit 8 (CCK8) assay was used to determine the EPI IC(50) in A549 cells treated for 72 h. A549 cells were treated with We...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285842/ https://www.ncbi.nlm.nih.gov/pubmed/32565933 http://dx.doi.org/10.3892/ol.2020.11567 |
_version_ | 1783544775774830592 |
---|---|
author | Liang, Ai-Ling Zhang, Jing Du, Shen-Lin Zhang, Bin Ma, Xuan Wu, Cui-Yun Liu, Yong-Jun |
author_facet | Liang, Ai-Ling Zhang, Jing Du, Shen-Lin Zhang, Bin Ma, Xuan Wu, Cui-Yun Liu, Yong-Jun |
author_sort | Liang, Ai-Ling |
collection | PubMed |
description | The present study investigated whether the autophagy inhibitor chloroquine (CQ) can improve the sensitivity of the A549 lung cancer cell line to epirubicin (EPI). The Cell Counting Kit 8 (CCK8) assay was used to determine the EPI IC(50) in A549 cells treated for 72 h. A549 cells were treated with Western blot analysis was performed to detect the expression level of the autophagy-associated protein, microtubule associated protein 1 light chain 3 β (LC3B), and apoptosis-associated proteins such as cleaved caspase-9 and cleaved caspase-3. CCK8, colony formation, wound healing and Transwell assays were performed to analyze cell proliferation, migration and invasion capacity. Reverse transcription-quantitative PCR (RT-qPCR) was used to analyze the mRNA expression levels of LC3B and beclin-1, and the apoptosis rate was analyzed by flow cytometry. The IC(50) of EPI was 0.03 µg/ml. The CCK8 results demonstrated that the cell survival rate was lower in CQ + EPI-treated cells when compared with the individual treatment groups. The colony formation results revealed that the number of clones in the EPI + CQ-treated group was reduced compared with EPI or CQ treatment alone. The wound healing assay revealed that migration was reduced in the EPI + CQ-treated group compared with the other treatment groups, and the Transwell results indicated that the number of cells passing through the Matrigel and membrane was lowest in the CQ + EPI treatment group. The mRNA expression levels of LC3B and beclin-1 were increased in the CQ + EPI group by 51.5 and 61.2%, respectively, when compared with the control group. The results indicated that LC3B protein expression was enhanced by EPI in a concentration-dependent manner, and the protein levels of cleaved caspase-3 and cleaved caspase-9 were higher in the combination group than in the EPI alone group. The flow cytometry results demonstrated that the apoptosis rate was highest in the EPI + CQ group. In conclusion, the autophagy inhibitor CQ increased the sensitivity of A549 cells to EPI, and the underlying mechanism of action may be associated with the activation of apoptosis. |
format | Online Article Text |
id | pubmed-7285842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-72858422020-06-18 Chloroquine increases the anti-cancer activity of epirubicin in A549 lung cancer cells Liang, Ai-Ling Zhang, Jing Du, Shen-Lin Zhang, Bin Ma, Xuan Wu, Cui-Yun Liu, Yong-Jun Oncol Lett Articles The present study investigated whether the autophagy inhibitor chloroquine (CQ) can improve the sensitivity of the A549 lung cancer cell line to epirubicin (EPI). The Cell Counting Kit 8 (CCK8) assay was used to determine the EPI IC(50) in A549 cells treated for 72 h. A549 cells were treated with Western blot analysis was performed to detect the expression level of the autophagy-associated protein, microtubule associated protein 1 light chain 3 β (LC3B), and apoptosis-associated proteins such as cleaved caspase-9 and cleaved caspase-3. CCK8, colony formation, wound healing and Transwell assays were performed to analyze cell proliferation, migration and invasion capacity. Reverse transcription-quantitative PCR (RT-qPCR) was used to analyze the mRNA expression levels of LC3B and beclin-1, and the apoptosis rate was analyzed by flow cytometry. The IC(50) of EPI was 0.03 µg/ml. The CCK8 results demonstrated that the cell survival rate was lower in CQ + EPI-treated cells when compared with the individual treatment groups. The colony formation results revealed that the number of clones in the EPI + CQ-treated group was reduced compared with EPI or CQ treatment alone. The wound healing assay revealed that migration was reduced in the EPI + CQ-treated group compared with the other treatment groups, and the Transwell results indicated that the number of cells passing through the Matrigel and membrane was lowest in the CQ + EPI treatment group. The mRNA expression levels of LC3B and beclin-1 were increased in the CQ + EPI group by 51.5 and 61.2%, respectively, when compared with the control group. The results indicated that LC3B protein expression was enhanced by EPI in a concentration-dependent manner, and the protein levels of cleaved caspase-3 and cleaved caspase-9 were higher in the combination group than in the EPI alone group. The flow cytometry results demonstrated that the apoptosis rate was highest in the EPI + CQ group. In conclusion, the autophagy inhibitor CQ increased the sensitivity of A549 cells to EPI, and the underlying mechanism of action may be associated with the activation of apoptosis. D.A. Spandidos 2020-07 2020-04-22 /pmc/articles/PMC7285842/ /pubmed/32565933 http://dx.doi.org/10.3892/ol.2020.11567 Text en Copyright: © Liang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Liang, Ai-Ling Zhang, Jing Du, Shen-Lin Zhang, Bin Ma, Xuan Wu, Cui-Yun Liu, Yong-Jun Chloroquine increases the anti-cancer activity of epirubicin in A549 lung cancer cells |
title | Chloroquine increases the anti-cancer activity of epirubicin in A549 lung cancer cells |
title_full | Chloroquine increases the anti-cancer activity of epirubicin in A549 lung cancer cells |
title_fullStr | Chloroquine increases the anti-cancer activity of epirubicin in A549 lung cancer cells |
title_full_unstemmed | Chloroquine increases the anti-cancer activity of epirubicin in A549 lung cancer cells |
title_short | Chloroquine increases the anti-cancer activity of epirubicin in A549 lung cancer cells |
title_sort | chloroquine increases the anti-cancer activity of epirubicin in a549 lung cancer cells |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285842/ https://www.ncbi.nlm.nih.gov/pubmed/32565933 http://dx.doi.org/10.3892/ol.2020.11567 |
work_keys_str_mv | AT liangailing chloroquineincreasestheanticanceractivityofepirubicinina549lungcancercells AT zhangjing chloroquineincreasestheanticanceractivityofepirubicinina549lungcancercells AT dushenlin chloroquineincreasestheanticanceractivityofepirubicinina549lungcancercells AT zhangbin chloroquineincreasestheanticanceractivityofepirubicinina549lungcancercells AT maxuan chloroquineincreasestheanticanceractivityofepirubicinina549lungcancercells AT wucuiyun chloroquineincreasestheanticanceractivityofepirubicinina549lungcancercells AT liuyongjun chloroquineincreasestheanticanceractivityofepirubicinina549lungcancercells |